Surgery Partners, Inc.
Price Action
Technical Summary
CONSOLIDATINGSurgery Partners, Inc. is in a consolidation phase, trading with mixed signals as moving averages converge. Relative strength is moderate (RS Rating: 62), indicating performance broadly in line with the market. Earnings growth of 7% provides fundamental context to the price action. However, with RSI at 76, the stock is extended and may be prone to a short-term pullback.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $15.24 | +11.55% | ABOVE |
| 50 SMA | $14.46 | +17.56% | ABOVE |
| 100 SMA | $14.01 | +21.32% | ABOVE |
| 150 SMA | $14.58 | +16.61% | ABOVE |
| 200 SMA | $15.96 | +6.54% | ABOVE |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is SGRY in an uptrend right now?
SGRY has a trend score of 2/4 based on Minervini's Stage Analysis. Currently showing partial alignment - 2 of 4 trend criteria are met.
Is SGRY overbought or oversold?
SGRY's RSI (14) is 76. The stock is in overbought territory (RSI > 70), which may signal a pullback.
Is SGRY outperforming the market?
SGRY has a Relative Strength (RS) Rating of 62 out of 99. SGRY is performing about average compared to the market.
Where is SGRY in its 52-week range?
SGRY is trading at $17.00, which is 71% of its 52-week high ($24.10) and 44% above its 52-week low ($11.41).
How volatile is SGRY?
SGRY has a Beta of 0.90 and 52-week volatility of 46%. It's less volatile than the S&P 500 - generally more stable.